Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study finds outbreak of Cipro web sites followed anthrax outbreak

13.09.2002


Web sites selling the prescription-only medication ciprofloxacin (also known by its brand name Cipro®) sprang up quickly following an anthrax outbreak in October 2001, according to a new study by researchers from the Case Western Reserve University (CWRU) School of Medicine. The study, published today in the American Journal of Medicine, also found that these Web sites provided poor quality information, had inadequate consumer safeguards, and charged high prices.



On Oct. 4, 2001, the U.S. Centers for Disease Control and Prevention reported the first case of an anthrax outbreak by mail. Immediately following the anthrax outbreak, numerous Web sites began selling ciprofloxacin, then the only U.S. Food and Drug Administration (FDA)-approved drug to treat anthrax exposure. The outbreak provided the research team with a unique opportunity to illustrate the general difficulties regulators have had with these so-called "Internet pharmacies" that sell prescription drugs directly to the general public.

The researchers compiled information on 59 Web sites selling ciprofloxacin without a prescription between Oct. 28 and Oct. 31, 2001. Twenty-three sites (39 percent) had been created during the two weeks following the Oct. 4, 2001 announcement of the anthrax outbreak. Within a month, 29 sites (49 percent) had discontinued ciprofloxacin sales.


"The host of Web sites we identified sprouted up within two weeks of the anthrax outbreak – one outbreak immediately following the other," said Alexander Tsai, a fourth-year CWRU medical student in the Dual Degree Program in Medicine and Health Services Research. "These online sales of prescription-only medications clearly do not involve any meaningful medical assessment, which is necessary when prescribing a potentially dangerous antibiotic like ciprofloxacin."

Most state medical practice acts stipulate that a physician must examine a patient before prescribing a medication. However, none of the Web sites in the CWRU study required the customer to mail or fax in a physician’s prescription. Forty-nine sites (81 percent) simply asked the customer to fill out an online questionnaire with minimal questions about the customer’s medical history and symptoms. The other eleven sites (19 percent) did not even require customers to fill out a medical questionnaire for purchase.

Tsai conducted this study with the help of Dr. Peter Lurie, deputy director of the Washington D.C.-based Public Citizen’s Health Research Group, and Dr. Ashwini Seghal, a nephrologist at MetroHealth Medical Center and an associate professor of medicine at CWRU. The researchers also had concerns about the quality of these Web sites. Seventeen of the 59 sites (29 percent) displayed no information about potential adverse effects, and 16 sites (27 percent) did not mention the danger of life-threatening allergic reactions if patients with a history of hypersensitivity to quinolone antibiotics (such as ciprofloxacin) use the drug. On eight sites (14 percent), the researchers documented false or misleading claims.

During the study period, state authorities brought enforcement actions against three of the Web sites in the CWRU study. Also in response to the Internet explosion of Web sites selling ciprofloxacin, the FDA ordered all private ciprofloxacin shipments arriving from overseas to be stopped at the border. Eleven of the 59 sites (19 percent) were based in foreign countries, while the rest were registered to U.S. addresses.

"The sale of prescription drugs on the Internet is both a federal and state issue, but neither has the resources or adequate legal authority to act quickly enough," said Lurie. "The problem is that feds have largely deferred to the states – but the states have not filled the regulatory vacuum."

Tsai said he was inspired to undertake the research project after studying the work of other researcher-activists. Sehgal teaches an "Activism and Medicine" elective class for CWRU medical students. More information about this class can be found at http://home.cwru.edu/activism

George Stamatis | EurekAlert!
Further information:
http://www.cwru.edu/
http://home.cwru.edu/activism

More articles from Studies and Analyses:

nachricht A sudden drop in outdoor temperature increases the risk of respiratory infections
11.01.2017 | University of Gothenburg

nachricht Urbanization to convert 300,000 km2 of prime croplands
27.12.2016 | Mercator Research Institute on Global Commons and Climate Change (MCC) gGmbH

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

A big nano boost for solar cells

18.01.2017 | Power and Electrical Engineering

Glass's off-kilter harmonies

18.01.2017 | Materials Sciences

Toward a 'smart' patch that automatically delivers insulin when needed

18.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>